NTRK1 and cancer: Notably, NTRK1 amplification and subsequent TrkA overexpression is more common than NTRK1 rearrangement and has been reported in a variety of cancers including breast, neuroblastoma, lung cancers, pancreas, ovary, and others (14–18).